Find the BEST weed in...
Cannabis Firms Take DEA to Court Over Rescheduling Rules
Nov 20, 2026
Source:
Tom Angell
Marijuana Moment
Cannabis companies have taken the Drug Enforcement Administration to court over the requirements attached to the federal government's rescheduling move, making it the biggest story in a busy day of marijuana policy news. The lawsuit puts a spotlight on how the rollout of rescheduling is playing out for businesses that expected a cleaner path to federal protections.
The legal challenge is only one piece of the day's developments. A Senate panel has adopted new stances on marijuana and psychedelics, a sign that both topics continue to find space in congressional conversations even as the details of those positions will take time to unpack. The mix of cannabis and psychedelic policy in the same discussion also shows how closely linked the two reform movements have become on Capitol Hill.
On the state level, Indiana's secretary of state is calling for cannabis to be allowed on the ballot. Indiana residents currently lack a mechanism to put measures directly before voters, so the comment points toward a broader debate about giving citizens a way to move legalization forward when lawmakers don't. Meanwhile, in Pennsylvania, officials in Philadelphia are urging the state to legalize marijuana, adding local pressure to a debate that has gone back and forth for years.
Together, these stories paint a picture of a reform landscape pulled in several directions at once. Federal rescheduling is moving ahead but drawing legal challenges, Congress is feeling out its positions, and state and local leaders are pushing for their own paths to change. For anyone who follows cannabis policy or works in the industry, the DEA lawsuit will be the item to watch, since a court ruling could reshape how companies work with federal regulators. The other developments are reminders that change is happening on many fronts at the same time.







